BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11719449)

  • 1. A genetically engineered influenza A virus with ras-dependent oncolytic properties.
    Bergmann M; Romirer I; Sachet M; Fleischhacker R; García-Sastre A; Palese P; Wolff K; Pehamberger H; Jakesz R; Muster T
    Cancer Res; 2001 Nov; 61(22):8188-93. PubMed ID: 11719449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis.
    Min JY; Li S; Sen GC; Krug RM
    Virology; 2007 Jun; 363(1):236-43. PubMed ID: 17320139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDCK cell line with inducible allele B NS1 expression propagates delNS1 influenza virus to high titres.
    van Wielink R; Harmsen MM; Martens DE; Peeters BP; Wijffels RH; Moormann RJ
    Vaccine; 2011 Sep; 29(40):6976-85. PubMed ID: 21787829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue of influenza virus expressing GFP from the NS1 reading frame.
    Kittel C; Sereinig S; Ferko B; Stasakova J; Romanova J; Wolkerstorfer A; Katinger H; Egorov A
    Virology; 2004 Jun; 324(1):67-73. PubMed ID: 15183054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA.
    Li S; Min JY; Krug RM; Sen GC
    Virology; 2006 May; 349(1):13-21. PubMed ID: 16466763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An A14U Substitution in the 3' Noncoding Region of the M Segment of Viral RNA Supports Replication of Influenza Virus with an NS1 Deletion by Modulating Alternative Splicing of M Segment mRNAs.
    Zheng M; Wang P; Song W; Lau SY; Liu S; Huang X; Mok BW; Liu YC; Chen Y; Yuen KY; Chen H
    J Virol; 2015 Oct; 89(20):10273-85. PubMed ID: 26223635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame.
    van Rikxoort M; Michaelis M; Wolschek M; Muster T; Egorov A; Seipelt J; Doerr HW; Cinatl J
    PLoS One; 2012; 7(5):e36506. PubMed ID: 22563505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis.
    Salvatore M; Basler CF; Parisien JP; Horvath CM; Bourmakina S; Zheng H; Muster T; Palese P; García-Sastre A
    J Virol; 2002 Feb; 76(3):1206-12. PubMed ID: 11773396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant peripheral nerve sheath tumors with high and low Ras-GTP are permissive for oncolytic herpes simplex virus mutants.
    Mahller YY; Rangwala F; Ratner N; Cripe TP
    Pediatr Blood Cancer; 2006 Jun; 46(7):745-54. PubMed ID: 16124003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutant type 2 herpes simplex virus deleted for the protein kinase domain of the ICP10 gene is a potent oncolytic virus.
    Fu X; Tao L; Cai R; Prigge J; Zhang X
    Mol Ther; 2006 May; 13(5):882-90. PubMed ID: 16569513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication.
    Bergmann M; Garcia-Sastre A; Carnero E; Pehamberger H; Wolff K; Palese P; Muster T
    J Virol; 2000 Jul; 74(13):6203-6. PubMed ID: 10846107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling.
    Zhirnov OP; Klenk HD
    Apoptosis; 2007 Aug; 12(8):1419-32. PubMed ID: 17468837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza A Virus Virulence Depends on Two Amino Acids in the N-Terminal Domain of Its NS1 Protein To Facilitate Inhibition of the RNA-Dependent Protein Kinase PKR.
    Schierhorn KL; Jolmes F; Bespalowa J; Saenger S; Peteranderl C; Dzieciolowski J; Mielke M; Budt M; Pleschka S; Herrmann A; Herold S; Wolff T
    J Virol; 2017 May; 91(10):. PubMed ID: 28250123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems.
    García-Sastre A; Egorov A; Matassov D; Brandt S; Levy DE; Durbin JE; Palese P; Muster T
    Virology; 1998 Dec; 252(2):324-30. PubMed ID: 9878611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.
    Vähä-Koskela MJ; Kallio JP; Jansson LC; Heikkilä JE; Zakhartchenko VA; Kallajoki MA; Kähäri VM; Hinkkanen AE
    Cancer Res; 2006 Jul; 66(14):7185-94. PubMed ID: 16849565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastoma.
    Yang WQ; Senger D; Muzik H; Shi ZQ; Johnson D; Brasher PM; Rewcastle NB; Hamilton M; Rutka J; Wolff J; Wetmore C; Curran T; Lee PW; Forsyth PA
    Cancer Res; 2003 Jun; 63(12):3162-72. PubMed ID: 12810644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment.
    Kittel C; Ferko B; Kurz M; Voglauer R; Sereinig S; Romanova J; Stiegler G; Katinger H; Egorov A
    J Virol; 2005 Aug; 79(16):10672-7. PubMed ID: 16051859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
    Jarnagin WR; Zager JS; Hezel M; Stanziale SF; Adusumilli PS; Gonen M; Ebright MI; Culliford A; Gusani NJ; Fong Y
    Cancer Gene Ther; 2006 Mar; 13(3):326-34. PubMed ID: 16138120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of phosphatidylinositol 3-kinase signaling by the nonstructural NS1 protein is not conserved among type A and B influenza viruses.
    Ehrhardt C; Wolff T; Ludwig S
    J Virol; 2007 Nov; 81(21):12097-100. PubMed ID: 17715214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.